Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Acadia Healthcare Company (ACHC) Invested Capital (2016 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Invested Capital for 16 consecutive years, with $2.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Invested Capital fell 37.24% to $2.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $2.0 billion, a 37.24% decrease, with the full-year FY2025 number at $2.0 billion, down 37.24% from a year prior.
  • Invested Capital was $2.0 billion for Q4 2025 at Acadia Healthcare Company, down from $3.1 billion in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $3.2 billion in Q4 2024 to a low of $2.0 billion in Q4 2025.
  • A 5-year average of $2.7 billion and a median of $2.8 billion in 2023 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: rose 27.82% in 2021, then tumbled 37.24% in 2025.
  • Acadia Healthcare Company's Invested Capital stood at $2.5 billion in 2021, then grew by 11.75% to $2.8 billion in 2022, then decreased by 0.8% to $2.8 billion in 2023, then rose by 12.07% to $3.2 billion in 2024, then crashed by 37.24% to $2.0 billion in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Invested Capital are $2.0 billion (Q4 2025), $3.1 billion (Q2 2025), and $3.1 billion (Q1 2025).